(454) Delayed opioid withdrawal in a patient receiving naloxegol: a case report

Opioid use for the treatment of chronic non-malignant pain has increased, with approximately 90% of patients in pain clinics receiving opioids. Gastrointestinal effects such as constipation are frequently reported. Treatments for opioid induced constipation has expanded, which includes the use of peripherally acting μ-opioid receptor antagonist such as Naloxegol. The authors present a case of delayed opioid withdrawal in an 86-year-old male receiving Naloxogel, whose medical history was significant for lumbar spinal stenosis, Coronary Artery Disease and Rheumatoid Arthritis.
Source: The Journal of Pain - Category: Materials Science Authors: Source Type: research